{
  "success": true,
  "pagesUsed": [
    0,
    1,
    2
  ],
  "modelUsed": "claude-opus-4-5",
  "confidence": 1.0,
  "amendmentDetails": {
    "studyAmendmentImpacts": [
      {
        "id": "impact_1",
        "amendmentId": "amend_1",
        "affectedSection": "Section 1.3 - Schedule of Activities (SoA)",
        "impactLevel": "Minor",
        "instanceType": "StudyAmendmentImpact",
        "description": "Added optional prescreening period (Period I) with Visit 601 for Lp(a) assessment"
      },
      {
        "id": "impact_2",
        "amendmentId": "amend_1",
        "affectedSection": "Section 1.3 - Schedule of Activities (SoA)",
        "impactLevel": "Administrative",
        "instanceType": "StudyAmendmentImpact",
        "description": "Clarified that Visit 1 procedures may be conducted over more than 1 day if all activities are completed within the allowable visit tolerance"
      },
      {
        "id": "impact_3",
        "amendmentId": "amend_1",
        "affectedSection": "Section 1.3 - Schedule of Activities (SoA)",
        "impactLevel": "Minor",
        "instanceType": "StudyAmendmentImpact",
        "description": "Added provision for prescreening visit to be repeated once with minimum 4 weeks between visits"
      },
      {
        "id": "impact_4",
        "amendmentId": "amend_1",
        "affectedSection": "Section 1.3 - Schedule of Activities (SoA)",
        "impactLevel": "Administrative",
        "instanceType": "StudyAmendmentImpact",
        "description": "Specified that prescreening visit timing deviation from 21 days will not be considered a protocol deviation"
      }
    ],
    "studyAmendmentReasons": [
      {
        "id": "reason_1",
        "amendmentId": "amend_1",
        "reasonText": "To provide a simple way for sites to determine whether participants meet Lp(a) criteria before full screening activities are initiated",
        "category": "Operational",
        "isPrimary": true,
        "instanceType": "StudyAmendmentReason"
      },
      {
        "id": "reason_2",
        "amendmentId": "amend_1",
        "reasonText": "To allow flexibility in prescreening location including study site, mobile healthcare, or alternate laboratory",
        "category": "Operational",
        "isPrimary": false,
        "instanceType": "StudyAmendmentReason"
      },
      {
        "id": "reason_3",
        "amendmentId": "amend_1",
        "reasonText": "To accommodate participants who may meet Lp(a) criteria at a later time by allowing one repeat of prescreening",
        "category": "Scientific",
        "isPrimary": false,
        "instanceType": "StudyAmendmentReason"
      }
    ],
    "studyChanges": [
      {
        "id": "change_1",
        "amendmentId": "amend_1",
        "changeType": "Addition",
        "instanceType": "StudyChange",
        "sectionNumber": "1.3",
        "afterText": "Period I - Optional Prescreening: The study includes an optional prescreening visit (Visit 601) as a simple way for sites to determine whether participants meet Lp(a) criteria, as assessed by a central laboratory assessment, before the full screening activities are initiated at Visit 1.",
        "summary": "Added new optional prescreening period (Period I) with Visit 601 for Lp(a) assessment"
      },
      {
        "id": "change_2",
        "amendmentId": "amend_1",
        "changeType": "Addition",
        "instanceType": "StudyChange",
        "sectionNumber": "1.3",
        "afterText": "The prescreening visit can be conducted at the study site, or remotely, for example, at a mobile healthcare or alternate laboratory.",
        "summary": "Added flexibility for prescreening visit location"
      },
      {
        "id": "change_3",
        "amendmentId": "amend_1",
        "changeType": "Addition",
        "instanceType": "StudyChange",
        "sectionNumber": "1.3",
        "afterText": "The optional prescreening visit can be repeated 1 time (no more) per participant if the investigator believes the participant would meet criteria at a later time, with a minimum of 4 weeks between visits.",
        "summary": "Added provision for one repeat of prescreening visit with 4-week minimum interval"
      },
      {
        "id": "change_4",
        "amendmentId": "amend_1",
        "changeType": "Clarification",
        "instanceType": "StudyChange",
        "sectionNumber": "1.3",
        "afterText": "Repeated sampling in the prescreening visit will not require re-consenting or assignment of a new participant identification number.",
        "summary": "Clarified that repeat prescreening does not require new consent or participant ID"
      },
      {
        "id": "change_5",
        "amendmentId": "amend_1",
        "changeType": "Clarification",
        "instanceType": "StudyChange",
        "sectionNumber": "1.3",
        "afterText": "A prescreening visit occurring longer or shorter than 21 days (3 weeks) from screening will not be considered a protocol deviation.",
        "summary": "Clarified that prescreening timing deviation is not a protocol deviation"
      },
      {
        "id": "change_6",
        "amendmentId": "amend_1",
        "changeType": "Clarification",
        "instanceType": "StudyChange",
        "sectionNumber": "1.3",
        "beforeText": "Visit 1 procedures may be conducted over more than 1 day as long as all activities are completed prior to Visit 2.",
        "afterText": "Visit 1 procedures may be conducted over more than 1 day if all activities are completed within the allowable visit tolerance.",
        "summary": "Modified Visit 1 procedure timing requirement to reference allowable visit tolerance"
      }
    ],
    "summary": {
      "impactCount": 4,
      "reasonCount": 3,
      "changeCount": 6
    }
  }
}